[{"indications": "Indications\u00a0HIV infection in combination with other antiretroviral drugs; prevention\r\nof maternal-fetal HIV transmission (see notes above under Pregnancy\r\nand Breast-feeding)", "name": "ZIDOVUDINE With lamivudine", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Nucleoside reverse transcriptase inhibitors", "ZIDOVUDINE", "With lamivudine"], "cautions": "Cautions\u00a0\n(From Nucleoside reverse transcriptase inhibitors: British National Formulary)\nNucleoside reverse transcriptase inhibitors; also haematological toxicity particularly with high dose and advanced\r\ndisease\u2014monitor full blood count after 4 weeks of treatment, then\r\nevery 3 months; vitamin B12 deficiency\r\n(increased risk of neutropenia); if anaemia or myelosuppression\r\noccur, reduce dose or interrupt treatment according to product literature,\r\nor consider other treatment; elderly; interactions: Appendix 1 (zidovudine)", "side-effects": "Side-effects\u00a0see notes above; also anaemia (may require transfusion),\r\ntaste disturbance, chest pain, influenza-like symptoms, paraesthesia,\r\nneuropathy, convulsions, dizziness, drowsiness, anxiety, depression,\r\nloss of mental acuity, myopathy, gynaecomastia, urinary frequency,\r\nsweating, pruritus, pigmentation of nails, skin and oral mucosa", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/69459.htm", "doses": ["By mouth, 250\u2013300\u00a0mg twice daily; child 1 month\u201318 years see BNF for Children", "Prevention of maternal-fetal HIV transmission, seek specialist\r\nadvice (combination therapy preferred)", "Patients temporarily unable to take zidovudine by mouth, by intravenous infusion over 1 hour, 0.8\u20131\u00a0mg/kg\r\nevery 4 hours (approximating to 1.2\u20131.5\u00a0mg/kg every 4 hours by mouth)\r\nusually for not more than 2 weeks; child 3 months\u201318 years see BNF for Children", "Name[Combivir\u00ae (ViiV) ] Tablets, f/c, scored, zidovudine 300\u00a0mg, lamivudine 150\u00a0mg, net price 60-tab pack\r\n= \u00a3300.12Dose\u00a01 tablet twice daily; child body-weight over 14\u00a0kg see BNF for\r\nChildrenNote\u00a0Tablets may be crushed and mixed with semi-solid\r\nfood or liquid just before administration"], "pregnancy": "Pregnancy\u00a0limited information available; manufacturer advises\r\nuse only if clearly indicated; see also Pregnancy"}, {"indications": "Indications\u00a0HIV infection in combination with other antiretroviral drugs; prevention\r\nof maternal-fetal HIV transmission (see notes above under Pregnancy\r\nand Breast-feeding)", "name": "ZIDOVUDINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.3 Antiviral drugs", "5.3.1 HIV infection", "Nucleoside reverse transcriptase inhibitors"], "cautions": "Cautions\u00a0\n(From Nucleoside reverse transcriptase inhibitors: British National Formulary)\nNucleoside reverse transcriptase inhibitors; also haematological toxicity particularly with high dose and advanced\r\ndisease\u2014monitor full blood count after 4 weeks of treatment, then\r\nevery 3 months; vitamin B12 deficiency\r\n(increased risk of neutropenia); if anaemia or myelosuppression\r\noccur, reduce dose or interrupt treatment according to product literature,\r\nor consider other treatment; elderly; interactions: Appendix 1 (zidovudine)", "side-effects": "Side-effects\u00a0see notes above; also anaemia (may require transfusion),\r\ntaste disturbance, chest pain, influenza-like symptoms, paraesthesia,\r\nneuropathy, convulsions, dizziness, drowsiness, anxiety, depression,\r\nloss of mental acuity, myopathy, gynaecomastia, urinary frequency,\r\nsweating, pruritus, pigmentation of nails, skin and oral mucosa", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4002.htm", "doses": ["By mouth, 250\u2013300\u00a0mg twice daily; child 1 month\u201318 years see BNF for Children", "Prevention of maternal-fetal HIV transmission, seek specialist\r\nadvice (combination therapy preferred)", "Patients temporarily unable to take zidovudine by mouth, by intravenous infusion over 1 hour, 0.8\u20131\u00a0mg/kg\r\nevery 4 hours (approximating to 1.2\u20131.5\u00a0mg/kg every 4 hours by mouth)\r\nusually for not more than 2 weeks; child 3 months\u201318 years see BNF for Children"], "pregnancy": "Pregnancy\u00a0limited information available; manufacturer advises\r\nuse only if clearly indicated; see also Pregnancy"}]